Skip to main content
Pharmadrug Inc. logo

Pharmadrug Inc. — Investor Relations & Filings

Ticker · PHRX ISIN · CA71716W2040 LEI · 529900PHQPAWL5ITEB39 CSE Manufacturing
Open in API
Filings indexed 475 across all filing types
Latest filing 2022-04-05 Regulatory Filings
Country CA Canada
Listing CSE PHRX

About Pharmadrug Inc.

https://pharmadrug.ca/

Pharmadrug Inc. is a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines. The company's primary focus areas include the clinical development of reformulated natural-based medicines aimed at treating unmet needs in oncology and infectious diseases. Additionally, Pharmadrug develops synthetic and biosynthetic formulations of existing drugs, specifically addressing opportunities related to the potential third wave of drug policy reform concerning controlled substances.

Recent filings

Filing Released Lang Actions
Material document(s).pdf
Regulatory Filings Classification · 95% confidence The document text contains only references to omitted pictures and no substantive textual content. The total character count is 913, which is very short and does not contain any financial data, report content, or detailed information. It appears to be a placeholder or an announcement with images omitted, lacking any report or detailed filing information. Given the absence of any report content and the short length, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2022-04-05 English
Material document(s).pdf
Regulatory Filings Classification · 95% confidence The document is a notification form related to the registration of manufacturers, importers, or distributors of active substances for medicinal products. It is issued by a governmental health authority (Landesamt für Gesundheit & Soziales Mecklenburg-Vorpommern) and contains registration details, legal basis references, and obligations for annual updates. The content is regulatory in nature, focusing on compliance and registration rather than financial performance, management changes, or shareholder information. The document length is short (3021 characters) and does not contain financial data or report analysis. It is not an announcement of a report but a regulatory notification form. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2022-04-05 English
Material document(s).pdf
Regulatory Filings Classification · 90% confidence The document text consists solely of placeholders indicating omitted pictures and contains no textual content or substantive information. The true document length is only 908 characters, which is very short and contains no report or announcement text. There is no indication of any report type, regulatory body, fiscal period, or financial data. Given the absence of any meaningful content, this document cannot be classified as a report or announcement type. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2022-04-05 English
Material document(s).pdf
Regulatory Filings Classification · 100% confidence The document is a permission certificate related to narcotics trade under a specific narcotics act, detailing allowed quantities and types of substances for a company. It is a regulatory or compliance document rather than a financial report, announcement, or presentation. It does not contain financial data, management information, or shareholder-related content. It is not an announcement of a report but a regulatory permission certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2022-04-05 English
Material document(s).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Union Format for a Wholesale Distribution Authorisation' and contains detailed information about the authorization number, holder, address, scope of authorization, and legal basis. It is issued by a health and social affairs authority (Landesamt für Gesundheit und Soziales Mecklenburg-Vorpommern). The content is regulatory in nature, related to wholesale distribution authorization for medicinal products, and does not contain financial data, earnings, management discussion, or shareholder information. It is not an announcement of a report but a regulatory authorization document. Given the nature and content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific financial or corporate filing categories.
2022-04-05 English
Material document(s).pdf
Regulatory Filings Classification · 100% confidence The document contains only two images labeled as confidential and no textual content or financial data. It is extremely short (87 characters) and does not provide any report, announcement, or detailed information. Therefore, it does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings without substantive content.
2022-04-05 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.